Recently, Zhang et al. [59] found salivary messenger-RNA biomarkers (KRAS, MBD3L2, ACRV1, and DPM1) could differentiate PC patients from those with chronic pancreatitis and from healthy controls. This evidence concerns the gene KRAS and pachyonychia congenita.